Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    CHG ENSOL Delivers Innovative Solutions for Climate Change at COP28

    December 7, 2023

    Unveiling the Future of Finance: IMA’s Middle East Annual Conference Focuses on Vision 2030

    December 7, 2023

    U.S. Polo Assn. Supports Star-Studded ‘Boo-Yah’ Night for The V Foundation for Cancer Research

    December 7, 2023
    Sudan Daily NewsSudan Daily News
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Sudan Daily NewsSudan Daily News
    Home » Hoth Therapeutics expands with Novel Alzheimer’s Treatment
    Health

    Hoth Therapeutics expands with Novel Alzheimer’s Treatment

    February 25, 2021
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Hoth Therapeutics, Inc., a biopharmaceutical company, announced it has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer’s disease.  

    Hoth also secured an exclusive license agreement with respect to the use of this drug for other indications. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is associated with the destruction of higher brain structures, such as those involved in memory and cognition. 

    The disease leads to deficits in cognitive function and declines in memory, learning, language, and in the ability to perform intentional and purposeful movements. The disease is predicted to increase at least threefold between 2000 and 2050, rendering AD a world-wide public health problem.

    
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth’s pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. 

    Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19.

    Related Posts

    Revolutionizing diabetes care with saliva tests replacing finger pricks

    December 5, 2023

    Start your day right with complex carbs to enhance weight loss and blood sugar control

    December 5, 2023

    New insights into natural remedies for heart health

    December 2, 2023

    Maximizing your diet with prunes and plums

    November 28, 2023

    Weekend workouts equally effective as daily routines, new study finds

    November 27, 2023

    Physical activity mitigates cognitive deficits caused by lack of sleep

    November 27, 2023
    Latest News

    Revolutionizing diabetes care with saliva tests replacing finger pricks

    December 5, 2023

    Economic uncertainty spurs unprecedented demand for gold.

    December 5, 2023

    New York, L.A., and San Francisco among the world’s most expensive

    December 5, 2023

    Shaping tomorrow’s technology today with the top 11 companies leading the AI revolution

    December 5, 2023

    Start your day right with complex carbs to enhance weight loss and blood sugar control

    December 5, 2023

    Innovative construction solutions unveiled at Dubai’s Big 5 Global

    December 5, 2023

    UAE and Morocco forge new path with innovative partnership declaration

    December 5, 2023

    $9 billion boost from Global Fund for climate-impacted health systems

    December 5, 2023
    © 2021 Sudan Daily News | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.